Back
Rigel Pharmaceuticals, Inc. Stock Predictions
Valuation Up 5,000%. Shares Now $0.85 - Still Early?
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Buy
71
RIGL
Rigel Pharmaceuticals, Inc.
Last Price:
$40.85
Seasonality Move:
4.89%
7 Day Trial
ALL ACCESS PASS
$
7
Share Price Moved. Momentum Hasn't Slowed.
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radiRigel Pharmaceuticals, Inc. Stock Forecast
-
Over the next 52 weeks, Rigel Pharmaceuticals, Inc. has on average historically risen by 1.3% based on the past 25 years of stock performance.
-
Rigel Pharmaceuticals, Inc. has risen higher in 11 of those 25 years over the subsequent 52-week period, corresponding to a historical accuracy of 44%
-
Is Rigel Pharmaceuticals, Inc. Stock Undervalued?The current Rigel Pharmaceuticals, Inc. [RIGL] share price is $40.78. The Score for RIGL is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
-
RIGL is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
Will Rigel Pharmaceuticals, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Rigel Pharmaceuticals, Inc. has on average historically risen by 1.3% based on the past 25 years of stock performance.
Rigel Pharmaceuticals, Inc. Stock Rating
Buy
71
Rigel Pharmaceuticals, Inc. (RIGL)
is a Buy
Is Rigel Pharmaceuticals, Inc. overpriced?
-
Rigel Pharmaceuticals, Inc. has risen higher in 11 of those 25 years over the subsequent 52-week period, corresponding to a historical accuracy of 44%
Rigel Pharmaceuticals, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
rigel.com
52-Week Data
52-Week High:
52.24
52-Week Low:
14.63
Prediction Charts
Market Cap:
740.2M
Price in USD:
40.78
Volume:
563.9K
Beta:
1.47
Technical Analysis
SMA50:
36.82
SMA100:
35.05
SMA200:
27.15
52-Wk Change:
114.52%
Stock Predictions
-
Is Rigel Pharmaceuticals, Inc. stock public?Yes, Rigel Pharmaceuticals, Inc. is a publicly traded company.
-
What is the Rigel Pharmaceuticals, Inc. stock quote today?The Rigel Pharmaceuticals, Inc. stock price is 40.78 USD today.
-
How to buy Rigel Pharmaceuticals, Inc. stock online?You can buy Rigel Pharmaceuticals, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-24 | 46.51 | 49.80 | 50.23 | 45.70 |
| Nov-25 | 49.57 | 49.56 | 50.00 | 47.65 |
| Nov-26 | 50.52 | 50.96 | 51.73 | 49.23 |
| Nov-28 | 51.45 | 50.49 | 52.24 | 50.06 |
| Dec-1 | 50.02 | 47.26 | 50.27 | 46.80 |
| Dec-2 | 47.82 | 44.41 | 47.82 | 43.81 |
| Dec-3 | 44.09 | 47.21 | 47.30 | 44.09 |
| Dec-4 | 47.13 | 47.38 | 48.50 | 46.76 |
| Dec-5 | 47.57 | 48.92 | 49.96 | 46.98 |
| Dec-8 | 47.87 | 43.40 | 48.00 | 39.60 |
| Dec-9 | 42.41 | 42.33 | 44.46 | 41.99 |
| Dec-10 | 42.51 | 41.22 | 43.45 | 41.14 |
| Dec-11 | 40.95 | 42.05 | 43.58 | 40.60 |
| Dec-12 | 42.09 | 40.78 | 42.26 | 40.52 |
Rigel Pharmaceuticals, Inc. Earnings
Rigel Pharmaceuticals, Inc. Earnings Report: Per Share Rigel Pharmaceuticals, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Rigel Pharmaceuticals, Inc. Forecast Revenue Growth
Rigel Pharmaceuticals, Inc. Stock Analysis: Historical quarterly revenues per share for Rigel Pharmaceuticals, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.35 per share, a decrease next quarter of $0.00 per share, an increase this year of $6.13 per share, and a decrease next year of $2.31 per share.
* Rigel Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.